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The second law [of thermodynam-
ics] is one of the all-time great laws
of science, for it illuminates why
anything—anything from the cooling
of hot matter to the formulation of a
thought—happens at all.
Peter Atkins.
Four laws that drive the universe
A commentary on
The role of mitochondria for the
regulation of cardiac alternans
by Florea, S. M., and Blatter, L. A.
(2010). Front. Physiol. 1:141. doi: 10.3389/
fphys.2010.00141
It seems already like a long time ago
that we used to think about heart fail-
ure as a problem in which mitochondria
and energy were not involved. Energy has
been for so long granted in the mind
of mainstream electrophysiologists, but
not anymore. Although energy can be
taken for granted under normal condi-
tions, this is not the case in heart fail-
ure where dysfunctional mitochondria,
lack of substrate, and downstream effects
become dominant factors. In the last
decade, this unrealistic assumption has
dramatically changed. Increasing experi-
mental evidence supports the role of mito-
chondrial malfunction in the origin of
arrhythmias (Aon et al., 2003; Akar et
al., 2005; O’Rourke et al., 2005; Jeong
et al., 2012; Aggarwal and Makielski,
2013).
A push forward of this idea came in
2010, when Frontiers in Physiology pub-
lished the work of Florea and Blatter
(2010), which showed that the propen-
sity for pacing-induced Ca2+ alternans
in atrial myocytes increases when the
mitochondrial membrane potential
(m) is dissipated or ATP synthesis
inhibited. Alternans—a well-established
risk factor for ventricular and atrial
dysrhythmias—occur in cardiac fail-
ure and during myocardial ischemia.
Hindering either of the two main compo-
nents of the energy transducingmachinery
of mitochondria: the energy flow (ATP)
and its main driving force (m), trigger
ailleurs Ca2+ alternans, or the beat-to-beat
variations in Ca2+ transient ampli-
tude at constant stimulation frequency.
Further enhancement of alternans also
occurred after inhibition of respiratory
complexes or the Ca2+-sensitive dehydro-
genases from the tricarboxylic acid cycle.
Together, these data suggested that factors
diminishing mitochondrial Ca2+ seques-
tration generate favorable conditions
for Ca2+ alternans. Affecting mitochon-
drial Ca2+ handling by decreasing either
uptake through the uniporter or extru-
sion through the Na+/Ca2+ exchanger
also increased alternans. Then, Florea
and Blatter made the following intrigu-
ing observation: alternans may happen in
the absence of effects on the sarcoplasmic
reticulum (SR) Ca2+ replenishment, and
despite impaired mitochondrial energet-
ics and Ca2+ dynamics. They suggested
that under these conditions cytosolic
ATP levels are still sufficiently high to
allow for normal sarcoendoplasmic retic-
ulum Ca2+ ATPase (SERCA) activity
and/or ATP for SERCA is supplied by
glycolysis.
In more recent work, Florea and Blatter
(2012) investigated pacing-induced alter-
nans to further explore the role exerted
by ATP supply from glycolysis or oxida-
tive phosphorylation or both, under
β-adrenergic stimulation in cat atrial
myocytes. They show that beta stimu-
lation abolishes Ca2+ alternans even in
the presence of selective inhibition of
either glycolytic or mitochondrial ATP
supply, both enhancers of alternans occur-
rence. Only severe deficit of energy supply
given by simultaneous inhibition of both
catabolic pathways prevented β-adrenergic
stimulation-mediated abrogation of Ca2+
alternans. The authors suggest that
enhanced Ca2+ sequestration together
with β-adrenergic-mediated effects on the
ryanodine receptor appear to act in tan-
dem to protect against pacing-induced
Ca2+ alternans. In fact, all cellular and
transport processes involving subcellu-
lar organelles that contribute to clear
cytosolic Ca2+ protect against alternans,
and that conditions that impair cytosolic
Ca2+ sequestration promote alternans.
Impairment of mitochondrial Ca2+
uptake during excitation-contraction (EC)
coupling can potentially have an impact on
alternans incidence, although its quantita-
tive importance is still a matter of debate.
In this scenario, beta adrenergic receptor
stimulation triggers a tug of war between
protective and enhancing effects on alter-
nans, the former through increase in Ca2+
sequestration and the latter by augmenting
SR load and fractional release.
Mitochondrial redox and energetic
functions are inextricably linked, and both
are liable in heart dysfunction in chronic
diseases such as obesity and diabetes
(Bugger and Abel, 2010; Tocchetti et al.,
2012). It is nowwell established that signif-
icant perturbations in the mitochondrial
redox environment trigger mitochondrial
m depolarization that under critical
conditions can scale up to the whole
heart, thereby producing fatal arrhyth-
mias (Aon et al., 2009; Kembro et al.,
in press). Reactive oxygen species (ROS)
affect cardiac ion channels, cytoplasmic
ionic balance, contractile proteins, and EC
coupling (Christians and Benjamin, 2012;
Aggarwal and Makielski, 2013). In this
context, the work of Florea and Blatter
poses several key questions worth inves-
tigating. What is the redox-dependence
of the pacing-induced alternans? Since
ROS also reduces the ability of SERCA
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and plasma membrane Ca2+ ATPase to
sequester cytosolic Ca2+ back into the SR
or its efflux from the cell (Aggarwal and
Makielski, 2013), could the propensity of
cells to exhibiting alternans increase under
oxidative challenge or pathological con-
ditions such as cardiac hypertrophy? Is
mitochondrial ROS signaling involved in
the alternans occurrence? These questions
point to the pivotal role of mitochondria in
health, disease, aging, and their potential
for generating, under critical conditions, a
higher propensity to arrhythmias.
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